BML Capital Management, LLC — 13F Holdings

2026 Q2  ·  19 Positions

2026 Q2 Portfolio Activity

In 2026 Q2, BML Capital Management, LLC maintained a portfolio of 19 distinct positions. The most significant new addition was CORE SCIENTIFIC INC NEW, now representing 0.17% of the total fund value. They heavily accumulated shares in ENGENE THERAPEUTICS INC, increasing the position by 1531.2%. The fund also reduced its exposure to ORAMED PHARMACEUTICALS INC by 72.6%.
Position History hover any row below to update
Loading…
BML Capital Management, LLC Greensboro, NC Hedge Fund / Deep Value Manager AUM $175M
PCA Score Concentration Risk
Risk ENB
Total Positions
19
Quarter
2026 Q2
Top Holding
ACRS (36.0%)
Top 10 Concentration
93.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-19 of 19

BML Capital Management, LLC Full Holdings List — 2026 Q2

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
ACRS
ACLARIS THERAPE...
Healthcare 35.98% 34.31% #1
Prev: #1
6.5
-2,275,000 -16.0%
P
S
11,975,000 $63,347,750 2023 Q4 13F Filing 2026-06-30 2026-08-07
AVIR
ATEA PHARMACEUT...
Healthcare 18.36% 24.38% #2
Prev: #2
6.0
-106,327 -1.5%
P
S
6,952,330 $32,328,335 2023 Q2 13F Filing 2026-06-30 2026-08-07
N/A
ENGENE THERAPEU...
Unknown 6.55% #3
Prev: #—
7.1
6,669,908
NEW
6,669,908 $11,538,941 13F Filing 2026-06-30 2026-08-07
KHC
KRAFT HEINZ CO
Consumer Defensive 6.24% 1.80% #4 7
Prev: #11
6.0
340,000 272.0%
P
S
465,000 $10,983,300 2026 Q1 13F Filing 2026-06-30 2026-08-07
OM
OUTSET MED INC
Healthcare 6.18% 4.69% #5
Prev: #5
5.5
617,500 32.5%
P
S
2,519,701 $10,885,108 2025 Q4 13F Filing 2026-06-30 2026-08-07
KMX
CARMAX INC
Consumer Cyclical 5.18% 4.14% #6 1
Prev: #7
4.1
17,500 11.3%
P
S
172,500 $9,123,525 2025 Q4 13F Filing 2026-06-30 2026-08-07
TLYS
TILLYS INC
Consumer Cyclical 5.13% 5.59% #7 3
Prev: #4
3.1
no change no change
P
S
2,150,000 $9,030,000 2022 Q4 13F Filing 2026-06-30 2026-08-07
PMVP
PMV PHARMACEUTI...
Healthcare 4.06% 4.24% #8 2
Prev: #6
2.1
10,000 0.2%
P
S
5,330,000 $7,142,200 2024 Q1 13F Filing 2026-06-30 2026-08-07
TIL
INSTIL BIO INC
Healthcare 2.82% 3.42% #9
Prev: #9
2.1
no change no change
P
S
645,600 $4,964,664 2024 Q1 13F Filing 2026-06-30 2026-08-07
TGT
TARGET CORP
Consumer Defensive 2.78% 2.92% #10
Prev: #10
2.1
no change no change
P
S
37,500 $4,897,875 2025 Q3 13F Filing 2026-06-30 2026-08-07
ORMP
ORAMED PHARMACE...
Healthcare 2.37% 6.91% #11 8
Prev: #3
0.9
-2,300,962 -72.6%
P
S
866,269 $4,166,754 2023 Q1 13F Filing 2026-06-30 2026-08-07
JANX
JANUX THERAPEUT...
Healthcare 1.35% 1.38% #12
Prev: #12
1.5
no change no change
P
S
154,961 $2,380,201 2026 Q1 13F Filing 2026-06-30 2026-08-07
PLRX
PLIANT THERAPEU...
Healthcare 1.00% 1.25% #13
Prev: #13
1.4
no change no change
P
S
1,546,137 $1,762,596 2025 Q4 13F Filing 2026-06-30 2026-08-07
N/A
CONNECT BIOPHAR...
Unknown 0.78% 0.69% #14
Prev: #14
2.8
164,400 40.2%
P
S
573,287 $1,364,423 13F Filing 2026-06-30 2026-08-07
IMA
IMAGENEBIO INC
Healthcare 0.67% 0.64% #15
Prev: #15
1.3
no change no change
P
S
200,730 $1,184,307 2025 Q3 13F Filing 2026-06-30 2026-08-07
WMT
WALMART INC
PUT
PUT Option 0.22% 0.21% #16
Prev: #16
1.1
no change no change
P
S
335 $386,088 2025 Q3 13F Filing 2026-06-30 2026-08-07
CORZ
CORE SCIENTIFIC...
PUT
PUT Option 0.17% #17
Prev: #—
3.6
800
NEW
800 $298,000 2026 Q2 13F Filing 2026-06-30 2026-08-07
TSLA
TESLA INC
PUT
PUT Option 0.15% #18
Prev: #—
3.6
375
NEW
375 $270,000 2025 Q2 13F Filing 2026-06-30 2026-08-07
KZR
KEZAR LIFE SCIE...
Healthcare 0.00% 3.43%
Sold All 😨
(Was: #8)
0.0
-720,787 -100.0%
CLOSED
$— 2024 Q4 13F Filing 2026-06-30 2026-08-07
Showing 1-19 of 19 holdings

Unlock Full BML Capital Management, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →